Drug
Rabeprazole clinical trials
Also written Pariet, Aciphex and E3810.
- studies test it
- 123
- open now
- 3
- in phase 3
- 27
- first study started
- 2001
Keep track of what changes. Save the Rabeprazole studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
120 studies that test it; most in 2005 (10)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 5 |
| 2004 | 6 |
| 2005 | 10 |
| 2006 | 5 |
| 2007 | 3 |
| 2008 | 9 |
| 2009 | 6 |
| 2010 | 10 |
| 2011 | 8 |
| 2012 | 2 |
| 2013 | 7 |
| 2014 | 5 |
| 2015 | 4 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 6 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 52
- Phase 2
- 13
- Phase 3
- 27
- Phase 4
- 25
- No phase
- 11
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 83 · Other 40
Eisai Inc. (12) · Eisai Co., Ltd. (10) · Pfizer (8) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (6) · Genentech, Inc. (5) · Hutchmed (4) · Janssen Research & Development, LLC (3) · GlaxoSmithKline (3)
Often tested with
Tested in the same studies.
Amoxicillin (10) · Clarithromycin (8) · Itraconazole (5) · Rifampin (5) · E-3810 (4) · Metronidazole (4) · Omeprazole (3) · Famotidine (3)
Studies
Open first, then newest update. How each study uses Rabeprazole is read from its arms, and is right about nine times in ten.
Testing it · 123
- Assessing the Effect of a Proton Pump Inhibitor on the Pharmacokinetics of DZD8586 in Healthy Participants (TAI-SHAN21)Not yet recruitingPhase 1Dizal PharmaceuticalsNCT07888569Written as Rabeprazole
- Efficacy And Safety of Bismuth-Tetracycline-Rabeprazole Triple For First-Line Eradication of Helicobacter Pylori InfectionNot yet recruitingNot applicableChih-An Shih, MDNCT07788053Written as Bismuth quadruple therapy
- Effect of ZaStaprazan on Platelet Reactivity of Clopidogrel After PercuTaneous CoronAry InteRventionRecruitingPhase 4Yonsei UniversityNCT07471867Written as Rabeprazole
- A Study to Learn How Different Forms of the Study Medicine Called PF-08049820 Are Absorbed and Eliminated in Healthy AdultsCompletedPhase 1PfizerNCT07597928Written as Rabeprazole
- A Study on the Effect of Food and Proton Pump Inhibitor on the Pharmacokinetics of HMPL-760 CapsulesCompletedPhase 1HutchmedNCT07643272Written as Rabeprazole and HMPL-760
- Comparison of Antisecretory Effect of a Single Dose of Rabeprazole 20 mg and Omeprazole 20 mg in Obese SubjectsCompletedPhase 2Nantes University HospitalNCT01136317Written as Rabeprazole
- A Study to Learn if a Medicine That Reduces Stomach Acid Affects the Blood Level of Study Medicine PF-08049820 in Healthy Chinese Adults.CompletedPhase 1PfizerNCT07284173Written as Rabeprazole
- Study to Evaluate the Effect of Rabeprazole Sodium Enteric-coated Tablets on the Pharmacokinetics of TQ05105 TabletsActive, not recruitingPhase 1Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT07608666Written as Rabeprazole sodium enteric-coated tablets
- Evaluate the Effects of Famotidine or Rabeprazole on the PK of NirogacestatCompletedPhase 1SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, GermanyNCT07171619Written as Nirogacestat and Rabeprazole
- Study of Single and Multiple Ascending Doses of ZE46-0134 in Healthy VolunteersCompletedPhase 1Lomond Therapeutics Holdings, Inc.NCT06399315Written as Rabeprazole, 20mg oral
- Clinical Study Aiming to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Administration of ZE50-0134 at 5 Dose Levels in Healthy VolunteersCompletedPhase 1Lomond Therapeutics Holdings, Inc.NCT06787131Written as Rabeprazole 20 mg
- A Study in Healthy Men to Compare Two Different Oral Formulations of BI 1810631 and to Test How Food or Rabeprazole Influence the Amount of BI 1810631 in the BloodCompletedPhase 1Boehringer IngelheimNCT05380947Written as Rabeprazole sodium
- Helicobacter Pylori Infection and Gastric Disease in Bhutan: First Community-Wide, Population-Based StudyCompletedNot applicableZero Helicobacter IGAN NetworkNCT07211880Written as Rabeprazole Sodium, Amoxicillin Hydrate, Clarithromycin
- A Study to Investigate the Effect of Increased Gastric pH on the Oral Bioavailability of the Orexin-2 Receptor Antagonist JNJ-42847922 in Healthy ParticipantsCompletedPhase 1Janssen Research & Development, LLCNCT02475161Written as Rabeprazole
- Evaluation of the Effect of Rifampin and Rabeprazole on the Pharmacokinetics of CamlipixantCompletedPhase 1Bellus Health Inc. - a GSK companyNCT05899829Written as Rabeprazole
- A Study of Maribavir Pediatric Formulation in Healthy Adult ParticipantsCompletedPhase 1TakedaNCT05918822Written as Rabeprazole
- Efficacy and Safety of Hou Gu Mi Xi in Patients With Peptic Ulcer DiseasesCompletedNot applicableJiangxi University of Traditional Chinese MedicineNCT03320538Written as Rabeprazole
- Fed Study of Rabeprazole Sodium Tablets 20 mg and Aciphex® Tablets 20 mgCompletedPhase 1Mylan Pharmaceuticals IncNCT00649493Written as Rabeprazole Sodium Tablets 20 mg
- HMPL-689 Drug Interaction Study With CYP3A Inhibitor/CYP2C9 Inhibitor/CYP3A Inducer/PPICompletedPhase 1HutchmedNCT05602597Written as Rabeprazole 40 mg
- A Relative Bioavailability Study Evaluating Two New Encorafenib FormulationsCompletedPhase 1PfizerNCT05446142Written as Rabeprazole tablet
See all 123 studies that test Rabeprazole →
Given in every arm · 26 — Rabeprazole is usual care beside what is tested
- Zuojin Wan Combined With Rabeprazole or Mosapride for the Treatment of Functional Dyspepsia Combined With DepressionNot yet recruitingNot applicableNanjing First Hospital, Nanjing Medical UniversityNCT06481371Written as Rabeprazole sodium enteric-coated tablets
- Helicobacter Pylori Eradication and Follow-upRecruitingPhase 4Shanghai Zhongshan HospitalNCT05061732Written as Rabeprazole
- Comparing the Extent to Which Three Different Formulations of LY4100511 (DC-853) Are Made Available in the Body, Alone and in the Presence of a Drug That Reduces Stomach AcidTerminatedPhase 1Eli Lilly and CompanyNCT06916143Written as Rabeprazole
- A Study to Evaluate the Safety and Tolerability of BMS-986408 Alone and in Combination With Nivolumab or Nivolumab and Ipilimumab in Participants With Advanced Solid TumorsCompletedPhase 1/2Bristol-Myers SquibbNCT05407675Written as Rabeprazole
- Efficacy and Safety of Rifasutenizol (TNP 2198), Rabeprazole and Amoxicillin in Participants With H. Pylori InfectionCompletedPhase 3TenNor Therapeutics (Suzhou) LimitedNCT05857163Written as Rabeprazole sodium enteric-coated tablets
- Study to Evaluate Safety, Drug Levels, Food and Relative Bioavailability of BMS-986365 in Healthy Adult Male ParticipantsCompletedPhase 1CelgeneNCT06417229Written as Rabeprazole
- The Safety and Tolerability, Pharmacokinetics of TNP-2092 Capsules in Combination With Rabeprazole Sodium Enteric-coated TabletsCompletedPhase 1TenNor Therapeutics Inc.NCT06337604Written as Rabeprazole sodium enteric-coated tablets
- Bioavailability of GDC-0134 and the Effect of Food and Proton Pump Inhibitor on Pharmacokinetics of GDC-0134 in Healthy Female ParticipantsCompletedPhase 1Genentech, Inc.NCT03237741Written as rabeprazole
- Efficacy and Safety After Multiple Doses of TNP-2198 Capsules, Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules in Helicobacter Pylori Infected-positive ParticipantsCompletedPhase 2TenNor Therapeutics (Suzhou) LimitedNCT06076694Written as Rabeprazole Sodium
- A Study to Evaluate Preliminary Helicobacter Pylori Eradication After Multiple Doses of TNP-2198 Capsules Combined With Rabeprazole Sodium Enteric-coated Tablets, or Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin CapsulesCompletedPhase 1/2TenNor Therapeutics (Suzhou) LimitedNCT06076681Written as Rabeprazole Sodium
- Efficacy of Therapy Based on Fecal Molecular Antimicrobial Susceptibility Tests for Helicobacter Pylori InfectionStatus unknownPhase 4Second Affiliated Hospital, School of Medicine, Zhejiang UniversityNCT05718609Written as Rabeprazole
- Efficacy and Safety of Dual Therapy as First-line Treatment for Hp InfectionStatus unknownPhase 4Second Affiliated Hospital, School of Medicine, Zhejiang UniversityNCT05419674Written as Rabeprazole
- Trimebutine Maleate Combined With Rabeprazole in Patients With Grade A or B Reflux Esophagitis Whose Symptoms Refractory to RabeprazoleWithdrawnPhase 4Xijing Hospital of Digestive DiseasesNCT02986685Written as rabeprazole
- Helicobacter Pylori Eradication With Berberine Plus Amoxicillin Triple Therapy Versus Bismuth-containing Quadruple TherapyCompletedPhase 4Xijing Hospital of Digestive DiseasesNCT04697186Written as Rabeprazole
- Efficacies of Hybrid and High-dose Dual Therapies for the First-line Anti-H Pylori TreatmentCompletedNot applicableChang Gung Memorial HospitalNCT05152004Written as Pariet
- A Study on the Impact of Rabeprazole-induced Elevated Stomach pH on APO-Dabigatran Exposure in Healthy VolunteersCompletedPhase 4Population Health Research InstituteNCT04157881Written as RABEprazole 20 Mg Oral Delayed Release Tablet
- Antibiotic Combination for H. Pylori Eradication in Penicillin-allergic PatientsStatus unknownPhase 4Shanghai Zhongshan HospitalNCT05023577Written as Rabeprazole
- Tetracycline Versus Doxycycline for HP Rescue TherapyStatus unknownPhase 4Shanghai Zhongshan HospitalNCT05018923Written as Rabeprazole
- PPI-amoxicillin for H. Pylori TreatmentStatus unknownPhase 4Shanghai Zhongshan HospitalNCT05014685Written as Rabeprazole
- Bismuth-Metronidazole Triple Therapy for H. Pylori First-line TreatmentStatus unknownPhase 4Shanghai Zhongshan HospitalNCT04667299Written as Rabeprazole
Showing 20 of 26.
As the comparator · 13 — what is tested is compared with Rabeprazole
- Comparison of Rabeprazole and Vonoprazan in the Prevention of Post-endoscopic Variceal Ligation Ulcer in Patients With CirrhosisNot yet recruitingPhase 3King George's Medical UniversityNCT07608536Written as Rabeprazol
- Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy, Vonoprazan-amoxicillin Dual Therapy and Proton Pump Inhibitor-based Standard Triple Therapy for Hp EradicationRecruitingNot applicableKaohsiung Medical UniversityNCT06349486Written as rabeprazole, amoxicillin, clarithromycin
- Efficacy and Safety of Keverprazan-amoxicillin Dual Therapy for Helicobacter Pylori First-line TreatmentRecruitingPhase 4Second Affiliated Hospital, School of Medicine, Zhejiang UniversityNCT07122024Written as Rabeprazole
- Food Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Tablets 20 mgCompletedPhase 1Mylan Pharmaceuticals IncNCT00649194Written as Aciphex® Tablets 20 mg
- Study on The Efficacy and Safety of Berberine-containing Triple Therapy in Helicobacter Pylori First-Line EradicationCompletedPhase 4Xijing Hospital of Digestive DiseasesNCT05014334Written as Rabeprazole
- A Study of Anaprazole Sodium Enteric-coated Tablets in the Treatment of Reflux EsophagitisStatus unknownPhase 2Xuanzhu Biopharmaceutical Co., Ltd.NCT05604261Written as Rabeprazole sodium 20 mg
- A RCT of Triple Therapy With Proton Pump Inhibitor vs Vonoprazan for Helicobacter Pylori GastritisStatus unknownPhase 4Changi General HospitalNCT03908619Written as Rabeprazole Sodium 20mg
- A Phase 2 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers.CompletedPhase 2Sihuan Pharmaceutical Holdings Group Ltd.NCT04503629Written as Rabeprazole sodium
- Effects of Ilaprazole on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone ESD.CompletedPhase 4Il-Yang Pharm. Co., Ltd.NCT02638584Written as Rabeprazole
- A Phase 3 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers.Status unknownPhase 3Sihuan Pharmaceutical Holdings Group Ltd.NCT04215653Written as Rabeprazole
- Comparison of the Effect of Rabeprazole 50 mg DDR Capsules and 20 mg Enteric-coated TabletsCompletedPhase 4Neutec Ar-Ge San ve Tic A.ŞNCT03037606Written as Pariet 20 mg Enteric Coated Tablets
- To Evaluate Efficacy and Safety of Z-215 in Erosive EsophagitisCompletedPhase 2Zeria PharmaceuticalNCT02463643Written as Rabeprazole Sodium
- Ilaprazole for the Treatment of Duodenal Ulcer in Chinese PatientsCompletedPhase 2/3Livzon Pharmaceutical Group Inc.NCT02847455Written as 10 mg Rabeprazole
Codes
What other systems call Rabeprazole · ClinicalTrials.gg INT008978
- MeSH (NLM) D064750RabeprazoleConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 32828355LLRABEPRAZOLEConfirmed FDA, NLM, Wikidata
- RxNorm 114979Confirmed FDA, Wikidata
- Wikidata Q3515(RS)-rabeprazoleConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C29410RabeprazoleOne source FDA
- DrugBank DB01129One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D064750 | Rabeprazole | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 32828355LL | RABEPRAZOLE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 114979 | — | Confirmed FDA, Wikidata |
| Wikidata | Q3515 | (RS)-rabeprazole | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C29410 | Rabeprazole | One source FDA |
| DrugBank | DB01129 | — | One source Wikidata |
Also registered as dexrabeprazole (UNII 65JK8810RM) and rabeprazole sodium (UNII 3L36P16U4R · RxNorm 226868).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.